Cites del registre

Cita APA (7th ed.)
Giordano, F. A., Layer, J. P., Turiello, R., Friker, L. L., Mirallas, O., Pregler, B. E. F., . . . Hölzel, M. (2026). L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: Expansion of the phase I/II GLORIA trial. Nature Portfolio.
Cita Chicago (17th ed.)
Giordano, Frank A., et al. L-RNA Aptamer-based CXCL12 Inhibition Combined with Radiotherapy and Bevacizumab in Newly-diagnosed Glioblastoma: Expansion of the Phase I/II GLORIA Trial. Nature Portfolio, 2026.
Cita MLA (9th ed.)
Giordano, Frank A., et al. L-RNA Aptamer-based CXCL12 Inhibition Combined with Radiotherapy and Bevacizumab in Newly-diagnosed Glioblastoma: Expansion of the Phase I/II GLORIA Trial. Nature Portfolio, 2026.
Atenció: Aquestes cites poden no estar 100% correctes.